Urgent Living-Donor Liver Transplantation in a Patient With Concurrent Active Tuberculosis: A Case Report

被引:3
|
作者
Jung, B. -H. [1 ]
Park, J. -I. [1 ]
Lee, S. -G. [2 ]
机构
[1] Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Surg, 875 Haeundae Ro, Busan 48108, South Korea
[2] Univ Ulsan, Asan Med Ctr, Div Hepatobiliary Surg & Liver Transplantat, Dept Surg,Coll Med, Seoul, South Korea
关键词
DRUG-INDUCED HEPATOTOXICITY; RISK-FACTORS; INFECTION; RECIPIENTS; POLYMORPHISMS; MANAGEMENT; HEPATITIS; DIAGNOSIS; THERAPY; FAILURE;
D O I
10.1016/j.transproceed.2018.02.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Although active tuberculosis (TB) is considered a contraindication for liver transplantation (LT), this is the only treatment in patients with liver failure and concurrent active TB. We report a case with successful urgent living-donor LT for irreversible liver failure in the presence of active TB. Case Presentation. A 48-year-old man, with a history of decompensated alcoholic liver cirrhosis, was presented with stupor. At admission, his consciousness had deteriorated to semi-coma, and his renal function also rapidly deteriorated to hepatorenal syndrome. A preoperative computed tomography scan of the chest revealed several small cavitary lesions in both upper lobes, and acid-fast bacillus stain from his sputum was graded 2+. Adenosine deaminase levels from ascites were elevated, suggesting TB peritonitis. A first-line anti-TB drug regimen was started immediately (rifampin, isoniazid, levofloxacin, and amikacin). An urgent living-donor LT was performed 2 days later. After LT, the regimen was changed to second-line anti-TB drugs (amikacin, levofloxacin, cycloserine, and pyridoxine). The sputum acid fast bacillus stain tested negative on postoperative day 10. His liver function remained well preserved, even after the reversion to first-line anti-TB treatment. The patient recovered without any anti-TB medication-related complications and was discharged. Conclusions. LT can be prudently performed as a life-saving option, particularly for patients with liver failure and concurrent active TB.
引用
收藏
页码:910 / 914
页数:5
相关论文
共 50 条
  • [31] Living-Donor Liver Transplantation in Hepatitis C Virus Era: A Report of 500 Consecutive Cases in a Single Center
    Wahab, M. A.
    Shehta, A.
    Elshoubary, M.
    Yassen, A. M.
    Elmorshedi, M.
    Salah, T.
    Sultan, A. M.
    Fathy, O.
    Elsarraf, W. R.
    Shiha, U.
    Zalata, K.
    Elghawalby, A. N.
    Eldesoky, M.
    Monier, A.
    Said, R.
    Elsabagh, A. M.
    Ali, M.
    Kandeel, A.
    Abdalla, U.
    Aboelella, M.
    Elsadany, M.
    Abdel-Khalek, E. E.
    Marwan, A.
    ElMorsi, F. M.
    Adly, R.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (05) : 1396 - 1406
  • [32] Biliary reconstruction and complications after living-donor liver transplantation
    Saidi, Reza F.
    Elias, Nahel
    Ko, Dicken Sc
    Kawai, Tatsou
    Markmann, James
    Cosimi, A. Benedict
    Hertl, Martin
    HPB, 2009, 11 (06) : 505 - 509
  • [33] Therapeutic hypothermia after cardiac arrest during living-donor liver transplant surgery A case report
    Park, Jaesik
    Kwak, Ju Eun
    Cho, Yun Jeong
    Choi, Ho Joong
    Choi, Hoon
    Chae, Min Suk
    Park, Chul Soo
    Choi, Jong Ho
    Hong, Sang Hyun
    MEDICINE, 2020, 99 (45) : E22513
  • [34] Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy
    Lei, Jianyong
    Yan, Lunan
    Wang, Wentao
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (11) : 1340 - 1346
  • [35] Living-Donor Liver Transplantation for a Large Hepatocellular Carcinoma in a Genetically Identical Twin Sister
    Koek, Ger
    Schmitz, Sophia M.
    Bednarsch, Jan
    Heise, Daniel
    Longerich, Thomas
    Bakers, Frank
    Trautwein, Christian
    Luedde, Tom
    Ulmer, Tom Florian
    Neumann, Ulf Peter
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (01): : 56 - 61
  • [36] Clinical Significance of the Cellular Pharmacodynamics of Tacrolimus in Living-Donor Liver Transplantation
    Mijiti, Abuduxukuer
    Matsuno, Naoto
    Takeuchi, Hironori
    Unezaki, Sakae
    Nagao, Takeshi
    Hirano, Toshihiko
    CELL TRANSPLANTATION, 2009, 18 (5-6) : 657 - 664
  • [37] Prevalence of Hypertension After Living-Donor Liver Transplantation: A Prospective Study
    Tong, M. -S.
    Chai, H. -T.
    Liu, W. -H.
    Chen, C. -L.
    Fu, M.
    Lin, Y. -H.
    Lin, C. -C.
    Chen, S. -M.
    Hang, C. -L.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (02) : 445 - 450
  • [38] Two cases of variceal haemorrhage during living-donor liver transplantation
    Matsusaki, T.
    Morimatsu, H.
    Sato, T.
    Matsumi, J.
    Okazaki, N.
    Umeda, Y.
    Morita, K.
    BRITISH JOURNAL OF ANAESTHESIA, 2011, 106 (04) : 537 - 539
  • [39] Endoscopic management of anastomotic stricture after living-donor liver transplantation
    Lee, Dong Wook
    Han, Jimin
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (02) : 261 - 268
  • [40] A modified heterotopic auxiliary living donor liver transplantation: report of a case
    Dou, Kefeng
    Wang, Desheng
    Tao, Kaishan
    Yue, Shuqiang
    Ti, Zhenyu
    Song, Zhenshun
    Li, Lin
    He, Yong
    Hou, Xiaojuan
    ANNALS OF HEPATOLOGY, 2014, 13 (03) : 399 - 403